Second-Line Tests in the Diagnosis of Adrenocorticotropic Hormone-Dependent Hypercortisolism

키워드

참고문헌 (72)

1. Nieman LK, "The diagnosis of Cushing’s syndrome: an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 93, pp.1526~1540 (2008)
2. Ceccato F, "Cushing’s syndrome: screening and diagnosis", High Blood Press Cardiovasc Prev, 23, pp.209~215 (2016)
3. Boscaro M, "Approach to the patient with possible Cushing’s syndrome", J Clin Endocrinol Metab, 94, pp.3121~3131 (2009)
4. Shimon I, "Screening for Cushing’s syndrome: is it worthwhile?", Pituitary, 18, pp.201~205 (2015)
5. Ceccato F, "The diagnostic accuracy of increased late night salivary cortisol for Cushing’s syndrome: a real-life prospective study", J Endocrinol Invest, 42, pp.327~335 (2019)
6. Arnaldi G, "Diagnosis and complications of Cushing’s syndrome: a consensus statement", J Clin Endocrinol Metab, 88, pp.5593~5602 (2003)
7. Nieman LK, "Treatment of Cushing’s syndrome: an Endocrine Society clinical practice guideline", J Clin Endocrinol Metab, 100, pp.2807~2831 (2015)
8. Lacroix A, "Cushing’s syndrome", Lancet, 386, pp.913~927 (2015)
9. Barbot M, "Cushing’s syndrome: overview of clinical presentation, diagnostic tools and complications", Best Pract Res Clin Endocrinol Metab, 34, pp.101380~ (2020)
10. Pecori Giraldi F, "Assessment of ACTH assay variability: a multicenter study", Eur J Endocrinol, 164, pp.505~512 (2011)
11. Hernández I, "Ectopic ACTH-secreting syndrome: a single center experience report with a high prevalence of occult tumor", Arch Med Res, 37, pp.976~980 (2006)
12. Isidori AM, "Conventional and nuclear medicine imaging in ectopic Cushing’s syndrome: a systematic review", J Clin Endocrinol Metab, 100, pp.3231~3244 (2015)
13. Barbot M, "Predicting late recurrence in surgically treated patients with Cushing’s disease", Clin Endocrinol, 79, pp.394~401 (2013)
14. Testa RM, "The usefulness of combined biochemical tests in the diagnosis of Cushing’s disease with negative pituitary magnetic resonance imaging", Eur J Endocrinol, 156, pp.241~248 (2007)
15. Lonser RR, "Cushing’s disease: pathobiology, diagnosis, and management", J Neurosurg, 126, pp.404~417 (2017)
16. Kola B, "Dynamic testing in Cushing’s syndrome", Pituitary, 11, pp.155~162 (2008)
17. Barbot M, "Second-line tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome", Pituitary, 19, pp.488~495 (2016)
18. Pecori Giraldi F, "The corticotropin-releasing hormone test in the diagnosis of ACTH-dependent Cushing’s syndrome: a reappraisal", Clin Endocrinol (Oxf), 54, pp.601~607 (2001)
19. Reimondo G, "The corticotrophin-releasing hormone test is the most reliable noninvasive method to differentiate pituitary from ectopic ACTH secretion in Cushing’s syndrome", Clin Endocrinol, 58, pp.718~724 (2003)
20. Vilar L, "The role of non-invasive dynamic tests in the diagnosis of Cushing’s syndrome", J Endocrinol Invest, 31, pp.1008~1013 (2008)
21. Suda T, "Evaluation of diagnostic tests for ACTH-dependent Cushing’s syndrome", Endocr J, 56, pp.469~476 (2009)
22. Ritzel K, "ACTH after 15 min distinguishes between Cushing’s disease and ectopic Cushing’s syndrome: a proposal for a short and simple CRH test", Eur J Endocrinol, 173, pp.197~204 (2015)
23. Frete C, "Non-invasive diagnostic strategy in ACTH-dependent Cushing’s syndrome", J Clin Endocrinol Metab, 105, pp.3273~3284 (2020)
24. Ceccato F, "Human corticotropin-releasing hormone tests: 10 years of real-life experience in pituitary and adrenal disease", J Clin Endocrinol Metab, 105, pp.dgaa564~ (2020)
25. Liu Z, "High positive predictive value of the combined pituitary dynamic enhanced MRI and high-dose dexamethasone suppression tests in the diagnosis of Cushing’s disease bypassing bilateral inferior petrosal sinus sampling", Sci Rep, 10, pp.14694~ (2020)
26. Aron DC, "Effectiveness versus efficacy: the limited value in clinical practice of high dose dexamethasone suppression testing in the differential diagnosis of adrenocorticotropin-dependent Cushing’s syndrome", J Clin Endocrinol Metab, 82, pp.1780~1785 (1997)
27. Lin LY, "Assessment of bilateral inferior petrosal sinus sampling (BIPSS) in the diagnosis of Cushing’s disease", J Chin Med Assoc, 70, pp.4~10 (2007)
28. Aytug S, "Assessment of the utility of the high-dose dexamethasone suppression test in confirming the diagnosis of Cushing disease", Endocr Pract, 18, pp.152~157 (2012)
29. Albiger NME, "Cyclic Cushing’s syndrome: an overview", Arq Bras Endocrinol Metab, 51, pp.1253~1260 (2007)
30. Ceccato F, "Dexamethasone measurement during low-dose suppression test for suspected hypercortisolism: threshold development with and validation", J Endocrinol Invest, 43, pp.1105~1113 (2020)
31. Young J, "Management of endocrine disease: Cushing’s syndrome due to ectopic ACTH secretion: an expert operational opinion", Eur J Endocrinol, 182, pp.R29~R58 (2020)
32. Colao A, "Inferior petrosal sinus sampling in the differential diagnosis of Cushing’s syndrome: results of an Italian multicenter study", Eur J Endocrinol, 144, pp.499~507 (2001)
33. Deipolyi A, "Bilateral inferior petrosal sinus sampling: experience in 327 patients", J Neurointerv Surg, 9, pp.196~199 (2017)
34. Bonelli FS, "Adrenocorticotropic hormone-dependent Cushing’s syndrome: sensitivity and specificity of inferior petrosal sinus sampling", Am J Neuroradiol, 21, pp.690~696 (2000)
35. Wind JJ, "The lateralization accuracy of inferior petrosal sinus sampling in 501 patients with Cushing’s disease", J Clin Endocrinol Metab, 98, pp.2285~2293 (2013)
36. Pereira CA, "Diagnostic accuracy of bilateral inferior petrosal sinus sampling: the experience of a tertiary centre", Exp Clin Endocrinol Diabetes, 129, pp.126~130 (2019)
37. Swearingen B, "Diagnostic errors after inferior petrosal sinus sampling", J Clin Endocrinol Metab, 89, pp.3752~3763 (2004)
38. Shi X, "Assessment of bilateral inferior petrosal sinus sampling in the diagnosis and surgical treatment of the ACTH-dependent Cushing’s syndrome: a comparison with other tests", Neuro Endocrinol Lett, 32, pp.865~873 (2011)
39. Lefournier V, "Accuracy of bilateral inferior petrosal or cavernous sinuses sampling in predicting the lateralization of Cushing’s disease pituitary microadenoma: influence of catheter position and anatomy of venous drainage", J Clin Endocrinol Metab, 88, pp.196~203 (2003)
40. Deipolyi AR, "Bilateral inferior petrosal sinus sampling using desmopressin or corticotropic-releasing hormone: a single-center experience", J Neurointerv Surg, 7, pp.690~693 (2015)
41. Zampetti B, "Bilateral inferior petrosal sinus sampling", Endocr Connect, 5, pp.R12~R25 (2016)
42. Castinetti F, "Desmopressin test during petrosal sinus sampling: a valuable tool to discriminate pituitary or ectopic ACTH-dependent Cushing’s syndrome", Eur J Endocrinol, 157, pp.271~277 (2007)
43. Machado MC, "The role of desmopressin in bilateral and simultaneous inferior petrosal sinus sampling for differential diagnosis of ACTH-dependent Cushing’s syndrome", Clin Endocrinol, 66, pp.136~142 (2007)
44. Chen S, "The optimal cut-off of BIPSS in differential diagnosis of ACTH-dependent Cushing’s syndrome: is stimulation necessary?", J Clin Endocrinol Metab, 105, pp.e1673~e1685 (2020)
45. Zilio M, "A venous thromboembolism risk assessment model for patients with Cushing’s syndrome", Endocrine, 52, pp.322~332 (2016)
46. Pecori Giraldi F, "Caution during use of desmopressin in IPSS", J Neurointerv Surg, 5, pp.e27~ (2013)
47. Luque RM, "A cellular and molecular basis for the selective desmopressin-induced ACTH release in Cushing disease patients: key role of AVPR1b receptor and potential therapeutic implications", J Clin Endocrinol Metab, 98, pp.4160~4169 (2013)
48. Vassiliadi DA, "Diagnosis of endocrine disease: the role of the desmopressin test in the diagnosis and follow-up of Cushing’s syndrome", Eur J Endocrinol, 178, pp.R201~R214 (2018)
49. Terzolo M, "The limited value of the desmopressin test in the diagnostic approach to Cushing’s syndrome", Clin Endocrinol, 54, pp.609~616 (2001)
50. Tsagarakis S, "The desmopressin and combined CRH-desmopressin tests in the differential diagnosis of ACTH-dependent Cushing’s syndrome: constraints imposed by the expression of V2 vasopressin receptors in tumors with ectopic ACTH secretion", J Clin Endocrinol Metab, 87, pp.1646~1653 (2002)
51. Colombo P, "Usefulness of the desmopressin test in the postoperative evaluation of patients with Cushing’s disease", Eur J Endocrinol, 143, pp.227~234 (2000)
52. Ambrogio AG, "Usefulness of desmopressin testing to predict relapse during long-term follow-up in patients in remission from Cushing’s disease", Endocr Connect, 6, pp.791~799 (2017)
53. Palermo M, "Urinary free cortisone and the assessment of 11 beta-hydroxysteroid dehydrogenase activity in man", Clin Endocrinol, 45, pp.605~611 (1996)
54. Ceccato F, "Monogenic forms of hypertension", Endocrinol Metab Clin North Am, 48, pp.795~810 (2019)
55. Funder JW, "Apparent mineralocorticoid excess", J Steroid Biochem Mol Biol, 165, pp.151~153 (2017)
56. Antonelli G, "Salivary cortisol and cortisone by LC-MS", MS: validation, reference intervals and diagnostic accuracy in Cushing’s syndrome, 2015, pp.451, 247~251
57. Gregori Casals, "Cortisol Measurements in Cushing's Syndrome: Immunoassay or Mass Spectrometry?", Annals of Laboratory Medicine, 40(4), pp.285~296 (2020), 대한진단검사의학회[DOI]
58. Ceccato F, "Diagnostic accuracy of increased urinary cortisol", cortisone ratio to differentiate ACTH-dependent Cushing’s syndrome, 2017, pp.87, 500~507
59. Yogi-Morren D, "Pituitary MRI findings in patients with pituitary and ectopic ACTH-dependent Cushing syndrome: does a 6-mm pituitary tumor size cut-off value exclude ectopic ACTH syndrome?", Endocr Pract, 21, pp.1098~1103 (2015)
60. Goroshi MR, "Comparison of 68Ga-DOTANOC PET", CT and contrast-enhanced CT in localisation of tumours in ectopic ACTH syndrome, 2016, pp.5, 83~91
61. ‐DOTATATE PET, "CT for the diagnosis and management of ectopic adrenocorticotropic hormone–secreting tumours", Clin Endocrinol, 91, pp.288~294 (2019)
62. Ceccato F, "The role of 68Ga-DOTA derivatives PET-CT in patients with ectopic ACTH syndrome", Endocr Connect, 9, pp.337~345 (2020)
63. Loriaux DL, "Diagnosis and differential diagnosis of Cushing’s syndrome", N Engl J Med, 376, pp.1451~1459 (2017)
64. Findling JW, "Diagnosis and differential diagnosis of Cushing’s syndrome", N Engl J Med, 377, pp.e3~ (2017)
65. Oelkers W, "Diagnosis and differential diagnosis of Cushing’s syndrome", N Engl J Med, 377, pp.e3~ (2017)
66. Goodman RL, "Diagnosis and differential diagnosis of Cushing’s syndrome", N Engl J Med, 377, pp.e3~ (2017)
67. Newell-Price J, "Optimal response criteria for the human CRH test in the differential diagnosis of ACTH-dependent Cushing’s syndrome", J Clin Endocrinol Metab, 87, pp.1640~1645 (2002)
68. Grant P, "Maximizing the accuracy of inferior petrosal sinus sampling: validation of the use of prolactin as a marker of pituitary venous effluent in the diagnosis of Cushing’s disease", Clin Endocrinol, 76, pp.555~559 (2012)
69. Sheth SA, "Transsphenoidal surgery for Cushing disease after nondiagnostic inferior petrosal sinus sampling", Neurosurgery, 71, pp.14~22 (2012)
70. Sakai Y, "Desmopressin stimulation test for diagnosis of ACTH-dependent Cushing’s syndrome", Endocr J, 44, pp.687~695 (1997)
71. Newell-Price J, "The desmopressin test and Cushing’s syndrome: current state of play", Clin Endocrinol, 47, pp.173~174 (1997)
72. Colombo P, "Effect of desmopressin on ACTH and cortisol secretion in states of ACTH excess", Clin Endocrinol, 46, pp.661~668 (1997)

관련 논문AI추천